| Ovanti Limited (OVT) ORDINARY FULLY PAID |
Communication Services |
$11 |
Half Yearly Report and Accounts
|
28 Feb 2025 3:24PM |
$0.008 |
$0.004 |
fallen by
50%
|
|
OVT - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss for the consolidated entity amounted to $4,734,891.
- Revenue from ordinary activities decreased by 37% to $2,075,144.
- The loss includes an impairment of $1,681,947 related to an investment in 1-Destinasi Sdn Bhd.
- No dividends were paid, recommended, or declared during the current financial period.
- The company appointed EAS Advisors for its USA BNPL expansion plans.
- A $6 million placement was completed to fund expansion efforts.
- The company is under investigation for potential fund misappropriation.
- Directors believe the company can continue as a going concern.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$1,415 |
Results of 2025 Extraordinary General Meeting
|
28 Feb 2025 3:24PM |
$3.815 |
$3.900 |
risen by
2.23%
|
|
| The Calmer Co International Limited (CCO) ORDINARY FULLY PAID |
Consumer Staple |
$9 |
Half Year Results Presentation
|
28 Feb 2025 3:21PM |
$0.006 |
$0.004 |
fallen by
41.67%
|
|
CCO - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues tripled to $4.36 million in H1 compared to H1 FY24.
- Net loss of $2.35 million due to marketing investments.
- Daily sales tracking at $25,000 per day.
- Gross profit margin of 52% achieved.
- Inventory levels increased by 58% to over $2 million.
- Net cash used in operations reduced by 50% in Q2 to $142,000 per month.
- Retail sales in Australia grew by 50% without advertising spend.
- Expansion into 846 Coles stores and 22 Quikstop convenience stores.
- Significant growth in the US market for kava products.
- Focus on cost control and operational efficiency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Grange Resources Limited (GRR) ORDINARY FULLY PAID |
Materials |
$237 |
Grange Full Yr Statutory Accts 12 Months Ended 31 Dec 2024
|
28 Feb 2025 3:20PM |
$0.225 |
$0.205 |
fallen by
8.89%
|
|
| The Calmer Co International Limited (CCO) ORDINARY FULLY PAID |
Consumer Staple |
$9 |
Half Yearly Report and Accounts
|
28 Feb 2025 3:19PM |
$0.006 |
$0.004 |
fallen by
41.67%
|
|
CCO - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for H1 FY25 was AU$4.36M, up 206% YoY.
- Net loss reported at AU$2.35M due to inventory buildup and ad spend.
- eCommerce sales accounted for 70% of total revenue.
- The company aims to expand into the US functional beverage markets.
- Strong growth in eCommerce customer acquisition, increasing by 600%.
- Taki Mai Kava Shots now available in over 500 stores in Australia.
- Cash position as of 31 December 2024 was AU$2.16M.
- Plans for launching flavored RTD shots in the USA by April 2025.
- Received an offer from the Fiji Development Bank for AU$1.8M to support facility acquisition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Grange Resources Limited (GRR) ORDINARY FULLY PAID |
Materials |
$237 |
Grange Resources Appendix 4E - 31 December 2024
|
28 Feb 2025 3:18PM |
$0.225 |
$0.205 |
fallen by
8.89%
|
|
GRR - Price-sensitive ASX Announcement
Full Release
Key Points
- Announcement date is 5 February 2024
- Company is Grange Resources Limited
- Revenue decreased by 15% from $614,744,000 to $520,805,000
- Profit after tax decreased by 61% from $150,104,000 to $58,549,000
- Net tangible asset backing per share increased from $0.89 to $0.92
- Financial report audited by PricewaterhouseCoopers
- No significant post-reporting matters affecting operations
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brightstar Resources Limited (BTR) ORDINARY FULLY PAID |
Materials |
$5,966 |
Half Year Accounts
|
28 Feb 2025 3:17PM |
$0.020 |
$0.505 |
risen by
2,489.74%
|
|
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$9 |
Appendix 4D and Half Year Financial Report
|
28 Feb 2025 3:16PM |
$0.140 |
$0.110 |
fallen by
21.43%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Invion Limited reported a loss of $1,872,230 for the half-year ended 31 December 2024.
- No revenue was recognized during the reporting period.
- The company is in discussions to expand rights to the Photosoft™ technology.
- A Phase II prostate cancer trial was successfully completed.
- A Phase I/II trial for non-melanoma skin cancer was initiated.
- Invion remains focused on advancing its clinical programs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Antipa Minerals Limited (AZY) ORDINARY FULLY PAID |
Materials |
$298 |
Ceasing to be a substantial holder
|
28 Feb 2025 3:16PM |
$0.350 |
$0.520 |
risen by
48.57%
|
|
| DomaCom Limited (DCL) ORDINARY FULLY PAID |
Financials |
- |
Delay in Lodgement of Appendix 4D and HY Financial Report
|
28 Feb 2025 3:15PM |
$0.011 |
$0.011 |
fallen by
0%
|
|
| Tasmea Limited (TEA) ORDINARY FULLY PAID |
Industrials |
$596 |
Change of Director's Interest Notice - Stephen Young
|
28 Feb 2025 3:13PM |
$2.930 |
$2.590 |
fallen by
11.60%
|
|
| Inventis Limited (IVT) ORDINARY FULLY PAID |
Industrials |
$2 |
Half Year Accounts
|
28 Feb 2025 3:13PM |
$0.024 |
$0.024 |
fallen by
0%
|
|
IVT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for the half year is $4,864,289, down 38% from last year.
- Loss from continuing operations is $1,731,631, an increase of 84.68%.
- Net loss for the period is $1,840,028, a 96.24% increase in losses.
- No interim dividend has been recommended.
- Directors are confident in meeting operational funding requirements for at least 12 months.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BSA Limited (BSA) ORDINARY FULLY PAID |
Industrials |
$6 |
BSA unsuccessful in new NBN Co Field Module contract bid
|
28 Feb 2025 3:12PM |
$0.094 |
$0.077 |
fallen by
18.09%
|
|
BSA - Price-sensitive ASX Announcement
Full Release
Key Points
- BSA Limited was unsuccessful in the new NBN Co Field Module contract bid.
- The tender was pursued in teaming with UGL.
- The existing nbn Unified Field Operations contract remains in place until 30 September 2025.
- Current contract volumes are stable and do not have guarantees.
- The contract comprises around 80% of BSA's revenue for FY2024.
- BSA is evaluating strategic options to mitigate the impact of losing the tender.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$3 |
Appendix 4E and 2024 Financial Report
|
28 Feb 2025 3:11PM |
$0.018 |
$0.013 |
fallen by
25.71%
|
|
IBX - Price-sensitive ASX Announcement
Full Release
Key Points
- Imagion Biosystems Limited reported a loss of $2,066,957 for 2024, significantly lower than the previous year's loss.
- The company raised $3 million in December 2024 for advancing its MagSense® technology.
- A licensing agreement was signed with Biosensis for the production and sale of PrecisionMRX® nanoparticles.
- The clinical development of the MagSense® HER2 imaging agent is resuming, with an FDA application planned for 2025.
- The financial statements were audited and received an unmodified opinion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TrivarX Ltd (TRI) ORDINARY FULLY PAID |
Health Care |
$7 |
Appendix 4D & Half-Year Financial Report to 31 December 2024
|
28 Feb 2025 3:11PM |
$0.016 |
$0.012 |
fallen by
25%
|
|
TRI - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased to $1,128,701 from $21,391 year-over-year.
- Net loss improved to $91,083 compared to a loss of $1,085,503 in the previous year.
- MEB-001, an AI-backed mental health screening algorithm, is progressing towards FDA approval.
- The company anticipates raising further capital for ongoing operations.
- TrivarX has strengthened its leadership team with new appointments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$93 |
Notification of cessation of securities - GSS
|
28 Feb 2025 3:10PM |
$0.555 |
$0.410 |
fallen by
26.13%
|
|
| Inghams Group Limited (ING) ORDINARY FULLY PAID |
Consumer Staple |
$1,279 |
Ceasing to be a substantial holder
|
28 Feb 2025 3:10PM |
$3.360 |
$3.440 |
risen by
2.38%
|
|
| Great Boulder Resources Limited (GBR) ORDINARY FULLY PAID |
Materials |
$57 |
Letter to Shareholders - GM Notice of Meeting
|
28 Feb 2025 3:10PM |
$0.071 |
$0.075 |
risen by
5.63%
|
|
| Frontier Energy Limited (FHE) ORDINARY FULLY PAID |
Utilities |
$88 |
Corporate Governance Statement and Appendix 4G
|
28 Feb 2025 3:09PM |
$0.115 |
$0.170 |
risen by
47.83%
|
|
| Echelon Resources Limited (ECH) ORDINARY FULLY PAID |
Energy |
$82 |
Updated Half Year Financial Statements (with auditor review)
|
28 Feb 2025 3:09PM |
$0.380 |
$0.365 |
fallen by
3.95%
|
|
| Great Boulder Resources Limited (GBR) ORDINARY FULLY PAID |
Materials |
$57 |
Notice of General Meeting/Proxy Form
|
28 Feb 2025 3:09PM |
$0.071 |
$0.075 |
risen by
5.63%
|
|
| LawFinance Limited (LAW) ORDINARY FULLY PAID |
Financials |
$0 |
Preliminary Final Report for the year ended 31 December 2023
|
28 Feb 2025 3:09PM |
$0.005 |
$0.005 |
fallen by
0%
|
|
| US Masters Residential Property Fund (URF) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$266 |
Quarterly Report - Q4 2024
|
28 Feb 2025 3:09PM |
$0.410 |
$0.385 |
fallen by
6.10%
|
|
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,479 |
Update - Notification of buy-back - GNC
|
28 Feb 2025 3:07PM |
$6.985 |
$6.670 |
fallen by
4.51%
|
|
| Linius Technologies Limited (LNU) ORDINARY FULLY PAID |
Information Technology |
$6 |
Notification regarding unquoted securities - LNU
|
28 Feb 2025 3:07PM |
$0.002 |
$0.001 |
fallen by
33.33%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
